The evaluation of efficacy and safety of sunitinib on EGFR-TKI pretreated advanced non-small cell lung cancer patients in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The evaluation of efficacy and safety of sunitinib on EGFR-TKI pretreated advanced non-small cell lung cancer patients in China

Published:2013-12-11 Issue:2 Volume:8 Page:206-212
ISSN:1752-6981
Container-title:The Clinical Respiratory Journal
language:en
Short-container-title:The Clinical Respiratory Journal

Author:

Liu You-ru¹,Zhu Wei²,Zhang Jian-liang³,Huang Jia-qi²,Zhao Yi-zhuo¹,Zhang Wei¹,Han Bao-hui¹,Yao Yi-hong²,Jiang Li-yan¹,Li Shan-qun⁴

Affiliation:

1. Department of Pulmonary; Shanghai Chest Hospital; Shanghai Jiao Tong University; Shanghai China

2. Translational Sciences; MedImmune; Gaithersburg MD USA

3. LLC; MedImmune; Gaithersburg MD USA

4. Department of Respiratory Medicine; Zhongshan Hospital; Fudan University; Shanghai China

Publisher

Wiley

Subject

Genetics(clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy

Reference30 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Estimation and projection of the national profile of cancer mortality in China: 1991-2005;Yang;Br J Cancer,2004

3. Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: current evidence and future perspectives;Custodio;Cancer Treat Rev,2013

4. Regulation of gene expression by progesterone in cancer cells: effects on cyclin D1, EGFR and VEGF;Hern Ndez-Hern Ndez;Mini Rev Med Chem,2013

5. Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer;Kono;Current Cancer Drug Targets,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Introductory Chapter: Protein Kinases as Promising Targets for Drug Design against Cancer;Protein Kinases - Promising Targets for Anticancer Drug Research;2021-12-08

2. The effectiveness of peer support on self-efficacy and self-management in people with type 2 diabetes: A meta-analysis;Patient Education and Counseling;2021-04

3. Preferences of dentists and endodontists, in Saudi Arabia, on management of necrotic pulp with acute apical abscess;BMC Oral Health;2018-06-19

4. How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?;Cancer Drug Resistance;2018-03-19

5. Kinase-targeted cancer therapies: progress, challenges and future directions;Molecular Cancer;2018-02-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3